speb/financial-data huggingface dataset:
CTM.V income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.00
CTM.V income_statement (quarterly, 2024-09-30) — Gain On Sale Of Ppe: 1050000.00
CTM.V cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: -18173.00
CTM.V cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: -18173.00
CTM.V cash_flow (quarterly, 2024-09-30) — Net Investment Purchase And Sale: 50000.00
CTM.V balance_sheet (quarterly, 2024-09-30) — Other Current Assets: -1.00
CTM.V balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: -1.00
CTM.V cash_flow (quarterly, 2024-09-30) — Sale Of Investment: 50000.00
CTM.V income_statement (annual, 2024-12-31) — +Operating Expense: 3235258.00
CTM.V income_statement (quarterly, 2024-12-31) — +Operating Expense: 876212.00
CTM.V income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
CTM.V income_statement (quarterly, 2024-12-31) — +Total Revenue: 0.00
CTM.V balance_sheet (annual, 2024-12-31) — Accounts Payable: 107525.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 107525.00
CTM.V balance_sheet (annual, 2024-12-31) — Accounts Receivable: 134034.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 134034.00
CTM.V cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 601157.00
CTM.V cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 590172.00
CTM.V income_statement (annual, 2024-12-31) — Basic Average Shares: 210640916.00
CTM.V income_statement (annual, 2024-12-31) — Basic EPS: -0.02
CTM.V cash_flow (annual, 2024-12-31) — Beginning Cash Position: 1821239.00
CTM.V cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 968252.00
CTM.V cash_flow (annual, 2024-12-31) — Capital Expenditure: -199204.00
CTM.V balance_sheet (annual, 2024-12-31) — Capital Stock: 134555766.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Capital Stock: 134555766.00
CTM.V balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 4889161.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 4889161.00
CTM.V balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 5326854.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 5326854.00
CTM.V cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 5951637.00
CTM.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Financing Activities: 4430018.00
CTM.V cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -149204.00
CTM.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: 0.00
CTM.V cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -2734511.00
CTM.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Operating Activities: -559109.00
CTM.V cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 19320.00
CTM.V cash_flow (quarterly, 2024-12-31) — Change In Payables And Accrued Expense: 199981.00
CTM.V cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 45806.00
CTM.V cash_flow (quarterly, 2024-12-31) — Change In Prepaid Assets: 3579.00
CTM.V cash_flow (annual, 2024-12-31) — Change In Receivables: -114986.00
CTM.V cash_flow (quarterly, 2024-12-31) — Change In Receivables: -42445.00
CTM.V cash_flow (annual, 2024-12-31) — Change In Working Capital: -49860.00
CTM.V cash_flow (quarterly, 2024-12-31) — Change In Working Capital: 161115.00
CTM.V cash_flow (annual, 2024-12-31) — Changes In Cash: 3067922.00
CTM.V cash_flow (quarterly, 2024-12-31) — Changes In Cash: 3920909.00
CTM.V balance_sheet (annual, 2024-12-31) — Common Stock: 134555766.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Common Stock: 134555766.00
CTM.V balance_sheet (annual, 2024-12-31) — Common Stock Equity: 20019031.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 20019031.00
CTM.V cash_flow (annual, 2024-12-31) — Common Stock Issuance: 5817056.00
CTM.V cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 4345437.00
CTM.V balance_sheet (annual, 2024-12-31) — Construction In Progress: 4000.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 4000.00
CTM.V balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 214384.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 214384.00
CTM.V balance_sheet (annual, 2024-12-31) — Current Assets: 5475999.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Current Assets: 5475999.00
CTM.V balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 692590.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 692590.00
CTM.V balance_sheet (annual, 2024-12-31) — Current Liabilities: 1014499.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 1014499.00
CTM.V income_statement (annual, 2024-12-31) — Diluted Average Shares: 210640916.00
CTM.V income_statement (annual, 2024-12-31) — Diluted EPS: -0.02
CTM.V income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -3239012.00
CTM.V income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: -1639593.00
CTM.V income_statement (annual, 2024-12-31) — EBIT: -3235258.00
CTM.V income_statement (quarterly, 2024-12-31) — EBIT: -876212.00
CTM.V income_statement (annual, 2024-12-31) — EBITDA: -3235258.00
CTM.V income_statement (quarterly, 2024-12-31) — EBITDA: -876212.00
CTM.V cash_flow (annual, 2024-12-31) — End Cash Position: 4889161.00
CTM.V cash_flow (quarterly, 2024-12-31) — End Cash Position: 4889161.00
CTM.V cash_flow (annual, 2024-12-31) — Financing Cash Flow: 5951637.00
CTM.V cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: 4430018.00
CTM.V cash_flow (annual, 2024-12-31) — Free Cash Flow: -2933715.00
CTM.V cash_flow (quarterly, 2024-12-31) — Free Cash Flow: -559109.00
CTM.V cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: -1077350.00
CTM.V cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of PPE: 15000.00
CTM.V income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 1077350.00
CTM.V income_statement (quarterly, 2024-12-31) — Gain On Sale Of Ppe: 27350.00
CTM.V income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -612428.00
CTM.V income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: -304712.00
CTM.V balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 2877346.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 2877346.00
CTM.V income_statement (annual, 2024-12-31) — General And Administrative Expense: 1191685.00
CTM.V income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 330714.00
CTM.V balance_sheet (annual, 2024-12-31) — Gross PPE: 15557531.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Gross PPE: 15557531.00
CTM.V income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 601157.00
CTM.V income_statement (quarterly, 2024-12-31) — Impairment Of Capital Assets: 590172.00
CTM.V income_statement (annual, 2024-12-31) — Insurance And Claims: 20999.00
CTM.V income_statement (quarterly, 2024-12-31) — Insurance And Claims: 7019.00
CTM.V income_statement (annual, 2024-12-31) — Interest Income: 35358.00
CTM.V income_statement (quarterly, 2024-12-31) — Interest Income: 7028.00
CTM.V income_statement (annual, 2024-12-31) — Interest Income Non Operating: 35358.00
CTM.V income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: 7028.00
CTM.V balance_sheet (annual, 2024-12-31) — Invested Capital: 20019031.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Invested Capital: 20019031.00
CTM.V cash_flow (annual, 2024-12-31) — Investing Cash Flow: -149204.00
CTM.V cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: 0.00
CTM.V cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 5817056.00
CTM.V cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 4345437.00
CTM.V cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 5817056.00
CTM.V cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 4345437.00
CTM.V income_statement (annual, 2024-12-31) — Net Income: -3239012.00
CTM.V income_statement (quarterly, 2024-12-31) — Net Income: -1639593.00
CTM.V income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -3239012.00
CTM.V income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: -1639593.00
CTM.V income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -3239012.00
CTM.V income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: -1639595.00
CTM.V income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -3239012.00
CTM.V income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -1639593.00
CTM.V income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -3239012.00
CTM.V income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -1639593.00
CTM.V cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -3239012.00
CTM.V cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: -1639593.00
CTM.V income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -3239012.00
CTM.V income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: -1639595.00
CTM.V income_statement (annual, 2024-12-31) — Net Interest Income: 35358.00
CTM.V income_statement (quarterly, 2024-12-31) — Net Interest Income: 7028.00
CTM.V income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 35358.00
CTM.V income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: 7028.00
CTM.V balance_sheet (annual, 2024-12-31) — Net PPE: 15557531.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Net PPE: 15557531.00
CTM.V cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -149204.00
CTM.V cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: 0.00
CTM.V balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 20019031.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 20019031.00
CTM.V income_statement (annual, 2024-12-31) — Normalized EBITDA: -3099023.00
CTM.V income_statement (quarterly, 2024-12-31) — Normalized EBITDA: -8678.00
CTM.V income_statement (annual, 2024-12-31) — Normalized Income: -3102777.00
CTM.V income_statement (quarterly, 2024-12-31) — Normalized Income: -772059.00
CTM.V cash_flow (annual, 2024-12-31) — Operating Cash Flow: -2734511.00
CTM.V cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: -559109.00
CTM.V cash_flow (annual, 2024-12-31) — Operating Gains Losses: -1077350.00
CTM.V cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: 15000.00
CTM.V income_statement (annual, 2024-12-31) — Operating Income: -3235258.00
CTM.V income_statement (quarterly, 2024-12-31) — Operating Income: -876212.00
CTM.V income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
CTM.V income_statement (quarterly, 2024-12-31) — Operating Revenue: 0.00
CTM.V balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 343321385.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 343321385.00
CTM.V income_statement (annual, 2024-12-31) — Other Gand A: 318864.00
CTM.V income_statement (quarterly, 2024-12-31) — Other Gand A: 116624.00
CTM.V income_statement (annual, 2024-12-31) — Other Income Expense: -39112.00
CTM.V income_statement (quarterly, 2024-12-31) — Other Income Expense: -770411.00
CTM.V cash_flow (annual, 2024-12-31) — Other Non Cash Items: -16363.00
CTM.V income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 97123.00
CTM.V income_statement (annual, 2024-12-31) — Other Operating Expenses: 1805717.00
CTM.V income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 496755.00
CTM.V balance_sheet (annual, 2024-12-31) — Other Properties: 15553531.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Other Properties: 15553531.00
CTM.V balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 437693.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 437693.00
CTM.V balance_sheet (annual, 2024-12-31) — Payables: 107525.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Payables: 107525.00
CTM.V balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 321909.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 321909.00
CTM.V balance_sheet (annual, 2024-12-31) — Prepaid Assets: 15111.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 15111.00
CTM.V income_statement (annual, 2024-12-31) — Pretax Income: -3239012.00
CTM.V income_statement (quarterly, 2024-12-31) — Pretax Income: -1639595.00
CTM.V cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 134581.00
CTM.V cash_flow (annual, 2024-12-31) — Purchase Of PPE: -199204.00
CTM.V cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: 0.00
CTM.V balance_sheet (annual, 2024-12-31) — Receivables: 134034.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Receivables: 134034.00
CTM.V income_statement (annual, 2024-12-31) — Rent And Landing Fees: 36914.00
CTM.V income_statement (quarterly, 2024-12-31) — Rent And Landing Fees: 7461.00
CTM.V income_statement (annual, 2024-12-31) — Rent Expense Supplemental: 36914.00
CTM.V income_statement (quarterly, 2024-12-31) — Rent Expense Supplemental: 7461.00
CTM.V income_statement (annual, 2024-12-31) — Research And Development: 237856.00
CTM.V income_statement (quarterly, 2024-12-31) — Research And Development: 48743.00
CTM.V balance_sheet (annual, 2024-12-31) — Retained Earnings: -117414081.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -117414081.00
CTM.V income_statement (annual, 2024-12-31) — Salaries And Wages: 814908.00
CTM.V income_statement (quarterly, 2024-12-31) — Salaries And Wages: 199610.00
CTM.V cash_flow (annual, 2024-12-31) — Sale Of PPE: 50000.00
CTM.V cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 0.00
CTM.V income_statement (annual, 2024-12-31) — Selling General And Administration: 1191685.00
CTM.V income_statement (quarterly, 2024-12-31) — Selling General And Administration: 330714.00
CTM.V balance_sheet (annual, 2024-12-31) — Share Issued: 343321385.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Share Issued: 343321385.00
CTM.V income_statement (annual, 2024-12-31) — Special Income Charges: 476193.00
CTM.V income_statement (quarterly, 2024-12-31) — Special Income Charges: -562822.00
CTM.V cash_flow (annual, 2024-12-31) — Stock Based Compensation: 434489.00
CTM.V cash_flow (quarterly, 2024-12-31) — Stock Based Compensation: 68198.00
CTM.V balance_sheet (annual, 2024-12-31) — Stockholders Equity: 20019031.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 20019031.00
CTM.V balance_sheet (annual, 2024-12-31) — Tangible Book Value: 20019031.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 20019031.00
CTM.V income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CTM.V income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CTM.V income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
CTM.V income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.00
CTM.V balance_sheet (annual, 2024-12-31) — Total Assets: 21033530.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Total Assets: 21033530.00
CTM.V balance_sheet (annual, 2024-12-31) — Total Capitalization: 20019031.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 20019031.00
CTM.V balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 20019031.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 20019031.00
CTM.V income_statement (annual, 2024-12-31) — Total Expenses: 3235258.00
CTM.V income_statement (quarterly, 2024-12-31) — Total Expenses: 876212.00
CTM.V balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 1014499.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 1014499.00
CTM.V balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 15557531.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 15557531.00
CTM.V balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
CTM.V income_statement (annual, 2024-12-31) — Total Unusual Items: -136235.00
CTM.V income_statement (quarterly, 2024-12-31) — Total Unusual Items: -867534.00
CTM.V income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -136235.00
CTM.V income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -867534.00
CTM.V cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 612428.00
CTM.V cash_flow (quarterly, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 262362.00
CTM.V balance_sheet (annual, 2024-12-31) — Working Capital: 4461500.00
CTM.V balance_sheet (quarterly, 2024-12-31) — Working Capital: 4461500.00
CTM.V income_statement (quarterly, 2025-03-31) — +Operating Expense: 1617671.00
CTM.V income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
CTM.V balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 120063.00
CTM.V cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 0.00
CTM.V income_statement (quarterly, 2025-03-31) — Basic Average Shares: 343321385.00
CTM.V income_statement (quarterly, 2025-03-31) — Basic EPS: 0.00
CTM.V cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 4889161.00
CTM.V cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -21955.00
CTM.V balance_sheet (quarterly, 2025-03-31) — Capital Stock: 134555766.00
CTM.V balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 3586431.00
CTM.V balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 4636457.00
CTM.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 0.00
CTM.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -21955.00
CTM.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -1280776.00
CTM.V cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 290971.00
CTM.V cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -56016.00
CTM.V cash_flow (quarterly, 2025-03-31) — Change In Receivables: 13971.00
CTM.V cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 248926.00
CTM.V cash_flow (quarterly, 2025-03-31) — Changes In Cash: -1302730.00
CTM.V balance_sheet (quarterly, 2025-03-31) — Common Stock: 134555766.00
CTM.V balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 19304613.00
CTM.V balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 4000.00
CTM.V balance_sheet (quarterly, 2025-03-31) — Current Assets: 4827645.00
CTM.V balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 489639.00
CTM.V balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1102518.00
CTM.V income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 343321385.00
CTM.V income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.00
CTM.V income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -789360.00
CTM.V income_statement (quarterly, 2025-03-31) — EBIT: -1617671.00
CTM.V income_statement (quarterly, 2025-03-31) — EBITDA: -1617671.00
CTM.V cash_flow (quarterly, 2025-03-31) — End Cash Position: 3586431.00
CTM.V cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 0.00
CTM.V cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -1302731.00
CTM.V cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 0.00
CTM.V income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 612333.00
CTM.V balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 2901135.00
CTM.V income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 246667.00
CTM.V balance_sheet (quarterly, 2025-03-31) — Gross PPE: 15579486.00
CTM.V income_statement (quarterly, 2025-03-31) — Impairment Of Capital Assets: 0.00
CTM.V income_statement (quarterly, 2025-03-31) — Insurance And Claims: 4790.00
CTM.V income_statement (quarterly, 2025-03-31) — Interest Income: 12847.00
CTM.V income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 12847.00
CTM.V balance_sheet (quarterly, 2025-03-31) — Invested Capital: 19304613.00
CTM.V cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -21955.00
CTM.V income_statement (quarterly, 2025-03-31) — Net Income: -789360.00
CTM.V income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -789360.00
CTM.V income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -789540.00
CTM.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -789360.00
CTM.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -789360.00
CTM.V cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -789360.00
CTM.V income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -789540.00
CTM.V income_statement (quarterly, 2025-03-31) — Net Interest Income: 12847.00
CTM.V income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 12847.00
CTM.V balance_sheet (quarterly, 2025-03-31) — Net PPE: 15579486.00
CTM.V cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -21955.00
CTM.V balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 19304613.00
CTM.V income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -2230004.00
CTM.V income_statement (quarterly, 2025-03-31) — Normalized Income: -1401693.00
CTM.V cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -1280776.00
CTM.V income_statement (quarterly, 2025-03-31) — Operating Income: -1617671.00
CTM.V income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
CTM.V balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 343321385.00
CTM.V income_statement (quarterly, 2025-03-31) — Other Gand A: 12560.00
CTM.V income_statement (quarterly, 2025-03-31) — Other Income Expense: 815284.00
CTM.V cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -202951.00
CTM.V income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 202951.00
CTM.V income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 1268028.00
CTM.V balance_sheet (quarterly, 2025-03-31) — Other Properties: 15575486.00
CTM.V balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 1050026.00
CTM.V balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 612879.00
CTM.V balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 71125.00
CTM.V income_statement (quarterly, 2025-03-31) — Pretax Income: -789540.00
CTM.V cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -21955.00
CTM.V balance_sheet (quarterly, 2025-03-31) — Receivables: 120063.00
CTM.V income_statement (quarterly, 2025-03-31) — Rent And Landing Fees: 25386.00
CTM.V income_statement (quarterly, 2025-03-31) — Rent Expense Supplemental: 25386.00
CTM.V income_statement (quarterly, 2025-03-31) — Research And Development: 102976.00
CTM.V balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -118152288.00
CTM.V income_statement (quarterly, 2025-03-31) — Salaries And Wages: 203931.00
CTM.V income_statement (quarterly, 2025-03-31) — Selling General And Administration: 246667.00
CTM.V balance_sheet (quarterly, 2025-03-31) — Share Issued: 343321385.00
CTM.V income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
CTM.V cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 74942.00
CTM.V balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 19304613.00
CTM.V balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 19304613.00
CTM.V income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CTM.V income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
CTM.V balance_sheet (quarterly, 2025-03-31) — Total Assets: 20407131.00
CTM.V balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 19304613.00
CTM.V balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 19304613.00
CTM.V income_statement (quarterly, 2025-03-31) — Total Expenses: 1617671.00
CTM.V balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1102518.00
CTM.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 15579486.00
CTM.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
CTM.V income_statement (quarterly, 2025-03-31) — Total Unusual Items: 612333.00
CTM.V income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 612333.00
CTM.V cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: -612333.00
CTM.V balance_sheet (quarterly, 2025-03-31) — Working Capital: 3725127.00
CTM.V income_statement (quarterly, 2025-06-30) — +Operating Expense: 1309021.00
CTM.V income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 351791.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 68636.00
CTM.V cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 0.00
CTM.V income_statement (quarterly, 2025-06-30) — Basic Average Shares: 343321385.00
CTM.V income_statement (quarterly, 2025-06-30) — Basic EPS: 0.00
CTM.V cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 3586431.00
CTM.V cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -1755.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Capital Stock: 134555766.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 3079462.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 3860450.00
CTM.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 0.00
CTM.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 179799.00
CTM.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -686768.00
CTM.V cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 454647.00
CTM.V cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 3987.00
CTM.V cash_flow (quarterly, 2025-06-30) — Change In Receivables: 51427.00
CTM.V cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 510061.00
CTM.V cash_flow (quarterly, 2025-06-30) — Changes In Cash: -506969.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Common Stock: 134555766.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 18197265.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 4000.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 715736.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Current Assets: 3996226.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 312675.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1380202.00
CTM.V income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 343321385.00
CTM.V income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.00
CTM.V income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -1191641.00
CTM.V income_statement (quarterly, 2025-06-30) — EBIT: -1309021.00
CTM.V income_statement (quarterly, 2025-06-30) — EBITDA: -1309021.00
CTM.V cash_flow (quarterly, 2025-06-30) — End Cash Position: 3079462.00
CTM.V cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 0.00
CTM.V cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -688522.00
CTM.V income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -87483.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 2985608.00
CTM.V income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 257017.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Gross PPE: 15581241.00
CTM.V income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 0.00
CTM.V income_statement (quarterly, 2025-06-30) — Insurance And Claims: 4790.00
CTM.V income_statement (quarterly, 2025-06-30) — Interest Income: 19043.00
CTM.V income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 19043.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Invested Capital: 18197265.00
CTM.V cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 179799.00
CTM.V income_statement (quarterly, 2025-06-30) — Net Income: -1191641.00
CTM.V income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -1191641.00
CTM.V income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -1191641.00
CTM.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -1191641.00
CTM.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -1191641.00
CTM.V cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -1191821.00
CTM.V income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -1191641.00
CTM.V income_statement (quarterly, 2025-06-30) — Net Interest Income: 19043.00
CTM.V income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 19043.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Net PPE: 15581241.00
CTM.V cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -1755.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 18197265.00
CTM.V income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -1221538.00
CTM.V income_statement (quarterly, 2025-06-30) — Normalized Income: -1104158.00
CTM.V cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -686767.00
CTM.V income_statement (quarterly, 2025-06-30) — Operating Income: -1309021.00
CTM.V income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 343321385.00
CTM.V income_statement (quarterly, 2025-06-30) — Other Gand A: 61566.00
CTM.V income_statement (quarterly, 2025-06-30) — Other Income Expense: 98337.00
CTM.V cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -176963.00
CTM.V income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 185820.00
CTM.V income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 1035259.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Other Properties: 15577241.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 780988.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Payables: 351791.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 1067527.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 67140.00
CTM.V income_statement (quarterly, 2025-06-30) — Pretax Income: -1191641.00
CTM.V cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -1755.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Receivables: 68636.00
CTM.V income_statement (quarterly, 2025-06-30) — Rent And Landing Fees: 17638.00
CTM.V income_statement (quarterly, 2025-06-30) — Rent Expense Supplemental: 17638.00
CTM.V income_statement (quarterly, 2025-06-30) — Research And Development: 16745.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -119344109.00
CTM.V income_statement (quarterly, 2025-06-30) — Salaries And Wages: 173023.00
CTM.V income_statement (quarterly, 2025-06-30) — Selling General And Administration: 257017.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Share Issued: 343321385.00
CTM.V income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
CTM.V cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 84473.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 18197265.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 18197265.00
CTM.V income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CTM.V income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Total Assets: 19577467.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 18197265.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 18197265.00
CTM.V income_statement (quarterly, 2025-06-30) — Total Expenses: 1309021.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1380202.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 15581241.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
CTM.V income_statement (quarterly, 2025-06-30) — Total Unusual Items: -87483.00
CTM.V income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -87483.00
CTM.V cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: 87483.00
CTM.V balance_sheet (quarterly, 2025-06-30) — Working Capital: 2616024.00
CTM.V income_statement (quarterly, 2025-09-30) — +Operating Expense: 1497384.00
CTM.V income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 926883.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 523908.00
CTM.V cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 0.00
CTM.V income_statement (quarterly, 2025-09-30) — Basic Average Shares: 345381057.00
CTM.V income_statement (quarterly, 2025-09-30) — Basic EPS: 0.00
CTM.V cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 3079462.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Capital Stock: 134844099.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1975407.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 2263019.00
CTM.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 163431.00
CTM.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 305260.00
CTM.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -1572746.00
CTM.V cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 199050.00
CTM.V cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -244937.00
CTM.V cash_flow (quarterly, 2025-09-30) — Change In Receivables: -455272.00
CTM.V cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -501159.00
CTM.V cash_flow (quarterly, 2025-09-30) — Changes In Cash: -1104055.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Common Stock: 134844099.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 17274411.00
CTM.V cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 4000.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 339694.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Current Assets: 3099004.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 139257.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 1405834.00
CTM.V income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 345381057.00
CTM.V income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.00
CTM.V income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -1163253.00
CTM.V income_statement (quarterly, 2025-09-30) — EBIT: -1497384.00
CTM.V income_statement (quarterly, 2025-09-30) — EBITDA: -1497384.00
CTM.V cash_flow (quarterly, 2025-09-30) — End Cash Position: 1975407.00
CTM.V cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 163431.00
CTM.V cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -1572746.00
CTM.V income_statement (quarterly, 2025-09-30) — Gain On Sale Of Ppe: 0.00
CTM.V income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -188116.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 2937674.00
CTM.V income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 158348.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Gross PPE: 15581241.00
CTM.V income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 0.00
CTM.V income_statement (quarterly, 2025-09-30) — Insurance And Claims: 3099.00
CTM.V income_statement (quarterly, 2025-09-30) — Interest Income: 12402.00
CTM.V income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 12402.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Invested Capital: 17274411.00
CTM.V cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 305260.00
CTM.V cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
CTM.V cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
CTM.V income_statement (quarterly, 2025-09-30) — Net Income: -1163253.00
CTM.V income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -1163253.00
CTM.V income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -1163253.00
CTM.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -1163253.00
CTM.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -1163253.00
CTM.V cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -1163253.00
CTM.V income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -1163253.00
CTM.V income_statement (quarterly, 2025-09-30) — Net Interest Income: 12402.00
CTM.V cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 305260.00
CTM.V income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 12402.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Net PPE: 15581241.00
CTM.V cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 0.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 17274411.00
CTM.V income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -1309268.00
CTM.V income_statement (quarterly, 2025-09-30) — Normalized Income: -975137.00
CTM.V cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -1572746.00
CTM.V income_statement (quarterly, 2025-09-30) — Operating Income: -1497384.00
CTM.V income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 345381057.00
CTM.V income_statement (quarterly, 2025-09-30) — Other Gand A: -6619.00
CTM.V income_statement (quarterly, 2025-09-30) — Other Income Expense: 321729.00
CTM.V cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -173418.00
CTM.V income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 509845.00
CTM.V income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 1275850.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Other Properties: 15577241.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 287612.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Payables: 926883.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 1266577.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 312077.00
CTM.V income_statement (quarterly, 2025-09-30) — Pretax Income: -1163253.00
CTM.V cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: 0.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Receivables: 523908.00
CTM.V income_statement (quarterly, 2025-09-30) — Rent And Landing Fees: 3000.00
CTM.V income_statement (quarterly, 2025-09-30) — Rent Expense Supplemental: 3000.00
CTM.V income_statement (quarterly, 2025-09-30) — Research And Development: 63186.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -120507362.00
CTM.V income_statement (quarterly, 2025-09-30) — Salaries And Wages: 158868.00
CTM.V cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 305260.00
CTM.V income_statement (quarterly, 2025-09-30) — Selling General And Administration: 158348.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Share Issued: 345381057.00
CTM.V income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
CTM.V cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 76968.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 17274411.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 17274411.00
CTM.V income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CTM.V income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Total Assets: 18680245.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 17274411.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 17274411.00
CTM.V income_statement (quarterly, 2025-09-30) — Total Expenses: 1497384.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1405834.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 15581241.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 0.00
CTM.V income_statement (quarterly, 2025-09-30) — Total Unusual Items: -188116.00
CTM.V income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -188116.00
CTM.V cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: 164311.00
CTM.V balance_sheet (quarterly, 2025-09-30) — Working Capital: 1693170.00
CTM.V income_statement (annual, 2025-12-31) — +Operating Expense: 6519039.00
CTM.V income_statement (quarterly, 2025-12-31) — +Operating Expense: 2094963.00
CTM.V income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
CTM.V income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
CTM.V balance_sheet (annual, 2025-12-31) — Accounts Payable: 153908.00
CTM.V balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 153908.00
CTM.V balance_sheet (annual, 2025-12-31) — Accounts Receivable: 170848.00
CTM.V balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 170848.00
CTM.V cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 0.00
CTM.V cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
CTM.V income_statement (annual, 2025-12-31) — Basic Average Shares: 347580659.00
CTM.V income_statement (annual, 2025-12-31) — Basic EPS: -0.01
CTM.V cash_flow (annual, 2025-12-31) — Beginning Cash Position: 4889161.00
CTM.V cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 1975407.00
CTM.V cash_flow (annual, 2025-12-31) — Capital Expenditure: -23710.00
CTM.V balance_sheet (annual, 2025-12-31) — Capital Stock: 141196113.00
CTM.V balance_sheet (quarterly, 2025-12-31) — Capital Stock: 141196113.00
CTM.V balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 7323695.00
CTM.V balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 7323695.00
CTM.V balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 7559992.00
CTM.V balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 7559992.00
CTM.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 7896928.00
CTM.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 7733497.00
CTM.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 521745.00
CTM.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 58641.00
CTM.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -5984140.00
CTM.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -2443850.00
CTM.V cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 65874.00
CTM.V cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -878794.00
CTM.V cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -214434.00
CTM.V cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 82532.00
CTM.V cash_flow (annual, 2025-12-31) — Change In Receivables: -36814.00
CTM.V cash_flow (quarterly, 2025-12-31) — Change In Receivables: 353060.00
CTM.V cash_flow (annual, 2025-12-31) — Change In Working Capital: -185374.00
CTM.V cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -443202.00
CTM.V cash_flow (annual, 2025-12-31) — Changes In Cash: 2434534.00
CTM.V cash_flow (quarterly, 2025-12-31) — Changes In Cash: 5348288.00
CTM.V balance_sheet (annual, 2025-12-31) — Common Stock: 141196113.00
CTM.V balance_sheet (quarterly, 2025-12-31) — Common Stock: 141196113.00
CTM.V balance_sheet (annual, 2025-12-31) — Common Stock Equity: 22234993.00
CTM.V balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 22234993.00
CTM.V cash_flow (annual, 2025-12-31) — Common Stock Issuance: 7709362.00
CTM.V cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 7709362.00
CTM.V balance_sheet (annual, 2025-12-31) — Construction In Progress: 4000.00
CTM.V balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 4000.00
CTM.V balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 233875.00
CTM.V balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 233875.00
CTM.V balance_sheet (annual, 2025-12-31) — Current Assets: 7960384.00
CTM.V balance_sheet (quarterly, 2025-12-31) — Current Assets: 7960384.00
CTM.V balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 918849.00
CTM.V balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 918849.00
CTM.V balance_sheet (annual, 2025-12-31) — Current Liabilities: 1306632.00
CTM.V balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 1306632.00
CTM.V income_statement (annual, 2025-12-31) — Diluted Average Shares: 347580659.00
CTM.V income_statement (annual, 2025-12-31) — Diluted EPS: -0.01
CTM.V income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -5075306.00
CTM.V income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -1930872.00
CTM.V income_statement (annual, 2025-12-31) — EBIT: -6519039.00
CTM.V income_statement (quarterly, 2025-12-31) — EBIT: -2094963.00
CTM.V income_statement (annual, 2025-12-31) — EBITDA: -6519039.00
CTM.V income_statement (quarterly, 2025-12-31) — EBITDA: -2094963.00
CTM.V cash_flow (annual, 2025-12-31) — End Cash Position: 7323695.00
CTM.V cash_flow (quarterly, 2025-12-31) — End Cash Position: 7323695.00
CTM.V cash_flow (annual, 2025-12-31) — Financing Cash Flow: 7896928.00
CTM.V cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 7733497.00
CTM.V cash_flow (annual, 2025-12-31) — Free Cash Flow: -6007850.00
CTM.V cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -2443851.00
CTM.V cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -268750.00
CTM.V cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -292555.00
CTM.V cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 0.00
CTM.V cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 0.00
CTM.V income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 0.00
CTM.V income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: 0.00
CTM.V income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 344059.00
CTM.V income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 7325.00
CTM.V balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 3413487.00
CTM.V balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 3413487.00
CTM.V income_statement (annual, 2025-12-31) — General And Administrative Expense: 993727.00
CTM.V income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 331695.00
CTM.V balance_sheet (annual, 2025-12-31) — Gross PPE: 15581241.00
CTM.V balance_sheet (quarterly, 2025-12-31) — Gross PPE: 15581241.00
CTM.V income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 0.00
CTM.V income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 0.00
CTM.V income_statement (annual, 2025-12-31) — Insurance And Claims: 21055.00
CTM.V income_statement (quarterly, 2025-12-31) — Insurance And Claims: 8376.00
CTM.V income_statement (annual, 2025-12-31) — Interest Income: 52945.00
CTM.V income_statement (quarterly, 2025-12-31) — Interest Income: 8653.00